LM
Congress trade
Rep. Lisa McClain (R-MI) bought $1K-$15K of ImmunityBio, Inc. (IBRX) stock
Lisa McClain, U.S. Representative (R-MI), disclosed a purchase of ImmunityBio, Inc. (IBRX) stock worth $1K-$15K in a STOCK Act filing on Oct 12, 2026.
The trade happened on Sep 30, 2026, 12 days before it was made public.
IBRX has moved +7.2% since the trade date, from $9.44 to $10.12 (Oct 12, 2026 close).
- Traded
- Sep 30, 2026
- Disclosed
- Oct 12, 2026
- Filing delay
- 12 days
- Price since
- +7.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (8)
More IBRX insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.